Also, 0.6 ± 0.3% of all live cells in the tumours of pHIFU + ICI-treated subjects were CD8+IFNγ+ T cells, whereas this was only 0.2 ± 0.1% in controls (figure 4d). This evidence concerns the gene CD8A and neoplasm.